Post-transplant Psychosocial and Mental Health Care of the Cardiac Recipient

  • Peter A. ShapiroEmail author
  • Luis F. Pereira
  • Katherine E. Taylor
  • Ilona Wiener


Heart transplantation offers patients with end-stage heart disease an opportunity for many additional years of life, with relief of heart failure and resumption of valued activities and social roles. Nevertheless, psychiatric problems are common and may undermine quality of life and survival. Important problems following transplantation include delirium, cognitive dysfunction, mood disorders, anxiety, post-traumatic stress disorder, sexual dysfunction, sleep disorders, and marital and family dysfunction. Steroids, immunosuppressants, and other medicines used in care of transplant recipients may cause psychopathology. Few controlled treatment studies have been conducted in psychiatric care of post-heart transplant recipients, so most treatment is based on uncontrolled case series, clinical experience, and extrapolation from other patient populations. Psychopharmacologic treatments are based on consideration of anticipated adverse effect profiles and drug interactions.


Heart Transplantation Psychiatric disorders Quality of life Treatment 



Supported in part by the Nathaniel Wharton Fund, New York, NY.


  1. 1.
    Shapiro PA. Life after heart transplantation. Prog Cardiovasc Dis. 1990;32:405–18.CrossRefGoogle Scholar
  2. 2.
    Shapiro PA. The process of acquiring and keeping an organ transplant. In: O’Reilly-Landry M, editor. A psychodynamic understanding of modern medicine: placing the person at the center of care. London: Radcliffe; 2012. p. 149–61.Google Scholar
  3. 3.
    Conway A, Schadewaldt V, Clark R, Ski C, Thompson DR, Doering L. The psychological experiences of adult heart transplant recipients: a systematic review and meta-summary of qualitative findings. Heart Lung. 2013;42:449–55.CrossRefGoogle Scholar
  4. 4.
    Paris W, Woodbury A, Thompson S, Levick M, Nothegger S, Slade-Hutkin L, Arbukle P, Cooper DKC. Social rehabilitation and return to work after cardiac transplantation-a multicenter survey. Transplantation. 1992;53:433–8.CrossRefGoogle Scholar
  5. 5.
    Shapiro PA, Williams DL, Foray AT, Gelman IS, Wukich N, Sciacca R. Psychosocial evaluation and prediction of compliance problems and morbidity after heart transplantation. Transplantation. 1995;60:1462–6.CrossRefGoogle Scholar
  6. 6.
    Shapiro PA. Psychiatric evaluation of potential heart transplant candidates as a predictor of post-heart transplant mortality. Paper presented at the annual meeting of the Academy of Psychosomatic Medicine, Nov. 19, 2011.Google Scholar
  7. 7.
    Maldonado J, Sher Y, Lolak S, Swendsen H, Skibola D, Neri E, David E, Sullivan C, Standridge K. The Stanford integrated psychosocial assessment for transplantation: a prospective study of medical and psychosocial outcomes. Psychosom Med. 2015;77:1018–30.CrossRefGoogle Scholar
  8. 8.
    Dew MA, Kormos RL, Roth LH, Murali S, Dimartini A, Griffith BP. Early post-transplant medical compliance and mental health predict physical morbidity and mortality one to three years after heart transplantation. J Heart Lung Transplant. 1999;18:546–62.CrossRefGoogle Scholar
  9. 9.
    Dew MA, Rosenberger EM, Myaskovsky L, DiMartini AF, DeVito Dabbs AJ, Posluszny DM, Steel J, Switzer GE, Shellmer DA, Greenhouse JB. Depression and anxiety as risk factors for morbidity and mortality after organ transplantation: a systematic review and meta-analysis. Transplantation. 2015;100:988–1003.PubMedPubMedCentralGoogle Scholar
  10. 10.
    Dobbels F, De Geest S, van Cleemput J, Droogne W, Vanhaecke J. Effect of late medication non-compliance on outcome after heart transplantation: a 5-year follow-up. J Heart Lung Transplant. 2004;23:1245–51.CrossRefGoogle Scholar
  11. 11.
    Stiefel P, Malehsa D, Bara C, Strueber M, Haverich A, Kugler C. Symptom experiences in patients after heart transplantation. J Health Psychol. 2013;18(5):680–92.CrossRefGoogle Scholar
  12. 12.
    DiMartini AF, Crone CC, Fireman M. Organ transplantation. In: Ferrando SJ, Levenson JL, Owen JA, editors. Clinical manual of psychopharmacology in the medically ill. Washington, DC: American Psychiatric Publishing; 2010. p. 469–99.Google Scholar
  13. 13.
    DiMartini A, Crone C, Fireman M, Dew MA. Psychiatric aspects of organ transplantation in critical care. Crit Care Clin. 2008;24:949–81.CrossRefGoogle Scholar
  14. 14.
    Flynn K, Daiches A, Malpus Z, Yonan N, Sanchez M. ‘A post-transplant person’: narratives of heart or lung transplantation and intensive care unit delirium. Health (London). 2014;18:352–68.CrossRefGoogle Scholar
  15. 15.
    Sockalingam S, Parekh N, Bogoch II, Sun J, Mahtani R, Beach C, Bollegalla N, Turzanski S, Seto E, Kim J, Dulay P, Scarrow S, Bhalerao S. Delirium in the postoperative cardiac patient: a review. J Card Surg. 2005;20:560–7.CrossRefGoogle Scholar
  16. 16.
    Dhar R. Neurologic complications of transplantation. Neurocrit Care. 2018 Feb;28(1):4–11. Scholar
  17. 17.
    Senzolo M, Ferronato C, Burra P. Neurologic complications after solid organ transplantation. Transpl Int. 2009;22:269–78.CrossRefGoogle Scholar
  18. 18.
    DiMartini A, Dew MA, Kormos R, McCurry K, Fontes P. Posttraumatic stress disorder caused by hallucinations and delusions experienced in delirium. Psychosomatics. 2007;48:436–9.CrossRefGoogle Scholar
  19. 19.
    Shapiro PA, Kornfeld DS. Psychiatric outcome of heart transplantation. Gen Hosp Psychiatry. 1989;11:352–7.CrossRefGoogle Scholar
  20. 20.
    Dew MA, Kormos RL, DiMartini AF, Switzer GE, Schulberg HC, Roth LH, Griffith BP. Prevalence and risk of depression and anxiety-related disorders during the first three years after heart transplantation. Psychosomatics. 2001;42:300–13.CrossRefGoogle Scholar
  21. 21.
    Freeman AM, Folks DG, Sokol RS, Fahs JJ. Cardiac transplantation: clinical correlates of psychiatric outcome. Psychosomatics. 1988;29:47–54.CrossRefGoogle Scholar
  22. 22.
    Dew MA, Roth LH, Schulberg HC, Simmons RG, Kormos RL, Trzepacz PT, Griffith BP. Prevalence and predictors of depression and anxiety-related disorders during the year after heart transplantation. Gen Hosp Psychiatry. 1996;18(6 Suppl):48s–61s.CrossRefGoogle Scholar
  23. 23.
    Grady KL, Naftel DC, Kobashigawa J, Chait J, Young JB, Pelegrin D, Czerr J, Heroux A, Higgins R, Rybarczyk B, McLeod M, White-Williams C, Kirklin JK. Patterns and predictors of quality of life at 5 to 10 years after heart transplantation. J Heart Lung Transplant. 2007;26:535–43.CrossRefGoogle Scholar
  24. 24.
    Fusar-Poli P, Martinelli V, Klersy C, Campana C, Callegari A, Barale F, Vigano M, Politi P. Depression and quality of life in patients living 10 to 18 years beyond heart transplantation. J Heart Lung Transplant. 2005;24:2269–78.CrossRefGoogle Scholar
  25. 25.
    Zipfel S, Schneider A, Wild B, Lowe B, Junger J, Haass M, Sack F, Bergmann G, Herzog W. Effect of depressive symptoms on survival after heart transplantation. Psychosom Med. 2002;64:740–7.Google Scholar
  26. 26.
    Shapiro PA. Nortriptyline treatment in depressed cardiac transplant recipients. Am J Psychiatry. 1991;148:371–3.CrossRefGoogle Scholar
  27. 27.
    Kay J, Bienenfeld D, Slomowitz M, Burk J, Zimmer L, Nadolny G, Marvel NT, Geier P. Use of tricyclic antidepressants in recipients of heart transplants. Psychosomatics. 1991;32:165–70.CrossRefGoogle Scholar
  28. 28.
    Horton R, Bonser R. Interaction between cyclosporine and fluoxetine. BMJ. 1995;311:422.CrossRefGoogle Scholar
  29. 29.
    Strouse T, Fairbanks L, Skotzko C. Fluoxetine and cyclosporine in organ transplantation. Failure to detect significant drug interactions or adverse clinical events in depressed organ recipients. Psychosomatics. 1996;37:23–30.CrossRefGoogle Scholar
  30. 30.
    Liston HL, Markowitz JS, Hunt N, DeVane CL, Boulton DW, Ashcraft E. Lack of citalopram effect on the pharmacokinetics of cyclosporine. Psychosomatics. 2001;42:370–2.CrossRefGoogle Scholar
  31. 31.
    Vella J, Sayegh M. Interactions between cyclosporine and newer antidepressant medications. Am J Kidney Dis. 1998;31:320–2.CrossRefGoogle Scholar
  32. 32.
    Fusar-Poli P, Picchioni M, Martinelli V, Bhattacharyya S, Cortesi M, Barale F, Politi P. Anti-depressive therapies after heart transplantation. J Heart Lung Transplant. 2006;25:785–93.CrossRefGoogle Scholar
  33. 33.
    Shapiro PA. Cardiovascular disorders. In: Levenson J, Ferrando S, editors. Clinical manual of psychopharmacology in the medically ill. 2nd ed. Arlington: American Psychiatric Association; 2017. p. 233–70.Google Scholar
  34. 34.
    Lee HB, Jayaram G, Teitelbaum ML. Electroconvulsive therapy for depression in a cardiac transplant patient. Psychosomatics. 2001;42:362–4.CrossRefGoogle Scholar
  35. 35.
    Conway A, Schadewaldt V, Clark R, Ski C, Thompson DR, Kynoch K, Doering L. The effectiveness of non-pharmacological interventions in improving psychological outcomes for heart transplant recipients: a systematic review. Eur J Cardiovasc Nurs. 2014;13:108–15.CrossRefGoogle Scholar
  36. 36.
    Dew MA, Goycoolea JM, Harris RC, Lee A, Zomak R, Dunbar-Jacob J, Rotondi A, Griffith BP, Kormos RL. An internet-based intervention to improve psychosocial outcomes in heart transplant recipients and family caregivers: development and evaluation. J Heart Lung Transplant. 2004;23(6):745–58.CrossRefGoogle Scholar
  37. 37.
    Stonnington CM, Darby B, Santucci A, Mulligan P, Pathuis P, Cuc A, Hentz JG, Zhang N, Mulligan D, Sood A. A resilience intervention involving mindfulness training for transplant patients and their caregivers. Clin Transpl. 2016;30:1466–72.CrossRefGoogle Scholar
  38. 38.
    Yardley M, Gullestad L, Bendz B, Bjorkelund E, Rolid K, Arora S, Nytroen K. Long-term effects of high-intensity interval training in heart transplant recipients: a five-year follow-up of a randomized clinical trial. Clin Transplant. 2017;31:e12868. Scholar
  39. 39.
    Beach SR, Celano CM, Noseworthy PA, Januzzi JL, Huffman JC. QTc prolongation, torsades de pointes, and psychotropic medications. Psychosomatics. 2013;54:1–13.CrossRefGoogle Scholar
  40. 40.
    Putzke JD, Williams MA, Daniel JF, Foley BA, Kirklin JK, Boll TJ. Neuropsychological functioning among heart transplant candidates: a case control study. J Clin Exp Neuropsychol. 2000;22:95–103.CrossRefGoogle Scholar
  41. 41.
    Festa JR, Jia X, Cheung K, Marchidann A, Schmidt M, Shapiro PA, Mancini DM, Naka Y, Deng M, Lantz ER, Marshall RS, Lazar RM. Association of low ejection fraction with impaired verbal memory in older patients with heart failure. Arch Neurol. 2011;68:1021–6.CrossRefGoogle Scholar
  42. 42.
    DeShields TL, McDonough EM, Mannen RK, Miller LW. Psychological and cognitive status before and after heart transplantation. Gen Hosp Psychiatry. 1996;18(6 Suppl):62S–9S.CrossRefGoogle Scholar
  43. 43.
    Schall RR, Petrucci RJ, Brozena SC, Cavarocchi NC, Jessup M. Cognitive function in patients with symptomatic dilated cardiomyopathy before and after cardiac transplantation. J Am Coll Cardiol. 1989;14:1666–72.CrossRefGoogle Scholar
  44. 44.
    Cupples SA, Stilley CS. Cognitive function in adult cardiothoracic transplant candidates and recipients. J Cardiovasc Nurs. 2005;20(5 Suppl):S74–87.CrossRefGoogle Scholar
  45. 45.
    Habib S, Khan A, Afridi MI, Saeed A, Jan AF, Amjad N. Frequency and predictors of cognitive decline in patients undergoing coronary artery bypass graft surgery. J Coll Physicians Surg Pak. 2014;24:543–8.PubMedGoogle Scholar
  46. 46.
    Grimm M, Yeganehfar W, Laufer G, Madl C, Kramer L, Eisenhuber E, Simon P, Kupilik N, Schreiner W, Pacher R, Bunzel B, Wolner E, Grimm G. Cyclosporine may affect improvement of cognitive brain function after successful cardiac transplantation. Circulation. 1996;94:1339–45.CrossRefGoogle Scholar
  47. 47.
    Bürker BS, Gullestad L, Gude E, Relbo Authen A, Grov I, Hol PK, Andreassen AK, Arora S, Dew MA, Fiane AE, Haraldsen IR, Malt UF, Andersson S. Cognitive function after heart transplantation: comparing everolimus-based and calcineurin inhibitor-based regimens. Clin Transpl. 2017;31 Scholar
  48. 48.
    Micuda S, Mundlova L, Anzenbacherova E, Anzenbacher P, Chladek J, Fuksa L, Martinkova J. Inhibitory effects of memantine on human cytochrome P450 activities: prediction of in vivo drug interactions. Eur J Clin Pharmacol. 2004;60:583–9.CrossRefGoogle Scholar
  49. 49.
    Polinsky RJ. Clinical pharmacology of rivastigmine: a new-generation acetylcholinesterase inhibitor for the treatment of Alzheimer’s disease. Clin Ther. 1998;20:634–47.CrossRefGoogle Scholar
  50. 50.
    Farlow MR. Clinical pharmacokinetics of Galantamine. Clin Pharmacokinet. 2003;42:1383–92.CrossRefGoogle Scholar
  51. 51.
    McEneny-King A, Edginton AN, Rao PP. Investigating the binding interactions of the anti-Alzheimer’s drug donepezil with CYP3A4 and P-glycoprotein. Bioorg Med Chem Lett. 2015;25:297–301.CrossRefGoogle Scholar
  52. 52.
    Jackson S, Ham RJ, Wilkinson D. The safety and tolerability of donepezil in patients with Alzheimer’s disease. Brit J Clin Pharmacol. 2004;58(Suppl. 1):1–8.CrossRefGoogle Scholar
  53. 53.
    Pudlo R, Piegza M, Zakliczyński M, Zembala M. The occurrence of mood and anxiety disorders in heart transplant recipients. Transplant Proc. 2009;41:3214–8.CrossRefGoogle Scholar
  54. 54.
    Crone CC, Gabriel GM. Treatment of anxiety and depression in transplant patients: pharmacokinetic considerations. Clin Pharmacokinet. 2004;43:361–94.CrossRefGoogle Scholar
  55. 55.
    Stukas AA, Dew MA, Switzer GE, DiMartini A, Kormos RL, Griffith BP. PTSD in heart transplant recipients and their primary family caregivers. Psychosomatics. 1999;40:212–21.CrossRefGoogle Scholar
  56. 56.
    Davydow DS, Lease ED, Reyes JD. Posttraumatic stress disorder in organ transplant recipients: a systematic review. Gen Hosp Psychiatry. 2015;37:387–98.CrossRefGoogle Scholar
  57. 57.
    Supelana C, Annunziato RA, Kaplan D, Helcer J, Stuber ML, Shemesh E. PTSD in solid organ transplant recipients: current understanding and future implications. Pediatr Transplant. 2016;20:23–33.CrossRefGoogle Scholar
  58. 58.
    Phan A, Ishak WW, Shen BJ, Fuess J, Philip K, Bresee C, Czer L, Schwarz ER. Persistent sexual dysfunction impairs quality of life after cardiac transplantation. J Sex Med. 2010;7:2765–73.CrossRefGoogle Scholar
  59. 59.
    Dew MA, DiMartini AF. Psychological disorders and distress after adult cardiothoracic transplantation. J Cardiovasc Nurs. 2005;20(5 Suppl):S51–66.CrossRefGoogle Scholar
  60. 60.
    Rembek M, Tylkowski M, Piestrzeniewicz K, Goch JH. Problems connected with sexual activity in patients with heart disease. Pol Merkur Lekarski. 2007;23:151–4.PubMedGoogle Scholar
  61. 61.
    Holtzman S, Abbey SE, Stewart DE, Ross HJ. Pain after heart transplantation: prevalence and implications for quality of life. Psychosomatics. 2010;51(3):230–6.CrossRefGoogle Scholar
  62. 62.
    Stein R, Sardinha A, Araújo CGS. Sexual activity and heart patients: a contemporary perspective. Can J Cardiol. 2016;32(4):410–20.CrossRefGoogle Scholar
  63. 63.
    Steinke EE, Jaarsma T, Barnason SA, Byrne M, Doherty S, Dougherty CM, Fridlund B, Kautz DD, Mårtensson J, Mosack V, Moser DK, Council on Cardiovascular and Stroke Nursing of the American Heart Association and the ESC Council on Cardiovascular Nursing and Allied Professions (CCNAP). Sexual counselling for individuals with cardiovascular disease and their partners: a consensus document from the American Heart Association and the ESC Council on Cardiovascular Nursing and Allied Professions (CCNAP). Eur Heart J. 2013;34:3217–35.CrossRefGoogle Scholar
  64. 64.
    Tseng PH, Shih FJ, Yang FC, Shih FJ, Wang SS. Factors contributing to poor sleep quality as perceived by heart transplant recipients in Taiwan. Transplant Proc. 2014;46:903–6.CrossRefGoogle Scholar
  65. 65.
    Reilly-Spong M, Park T, Gross CR. Poor sleep in organ transplant recipients: self-reports and actigraphy. Clin Transpl. 2013;27:901–13.CrossRefGoogle Scholar
  66. 66.
    Javaheri S, Abraham WT, Brown C, Nishiyama H, Giesting R, Wagoner LE. Prevalence of obstructive sleep apnoea and periodic limb movement in 45 subjects with heart transplantation. Eur Heart J. 2004;25:260–6.CrossRefGoogle Scholar
  67. 67.
    Vitinius F, Ziemke M, Albert W. Adherence with immunosuppression in heart transplant recipients. Curr Opin Organ Transplant. 2015;20:193–7.CrossRefGoogle Scholar
  68. 68.
    Kung M, Koschwanez HE, Painter L, Honeyman V, Broadbent E. Immunosuppressant nonadherence in heart, liver, and lung transplant patients: associations with medication beliefs and illness perceptions. Transplantation. 2012;93:958–63.CrossRefGoogle Scholar
  69. 69.
    Marcelino CA, Díaz LJ, da Cruz DM. The effectiveness of interventions in managing treatment adherence in adult heart transplant patients: a systematic review. JBI Database System Rev Implement Rep. 2015;13:279–308.PubMedGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2019

Authors and Affiliations

  • Peter A. Shapiro
    • 1
    Email author
  • Luis F. Pereira
    • 1
  • Katherine E. Taylor
    • 1
    • 2
  • Ilona Wiener
    • 1
  1. 1.Department of PsychiatryColumbia University Irving Medical CenterNew YorkUSA
  2. 2.Department of PsychiatryNew York University Medical CenterNew YorkUSA

Personalised recommendations